Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 4 (4 total).

American Academy of Pediatrics. 2008. Safe and healthy beginnings: A resource toolkit for hospitals and physician's offices. Elk Grove Village, IL: American Academy of Pediatrics, 7 items.

Annotation: This toolkit provides materials and resources for improving the care of newborns, focusing on risk for severe hyperbilirubinemia, breastfeeding support, and coordination of care. The toolkit is designed for pediatric health professionals who care for newborns in the office and hospital settings. The kit includes several print documents and a CD-ROM with readiness checklists, follow-up letters, assessment and documentation tools, coding resources, parent handouts, and more. Parent handouts are available in English and Spanish.

Contact: American Academy of Pediatrics, 345 Park Boulevard, Itasca, IL 60143, Telephone: (630) 626-6000 Secondary Telephone: (847) 434-4000 Fax: (847) 434-8000 Web Site: https://www.aap.org Non-member price $79.95, plus shipping and handling; Member price $69.95, plus shipping and handling.

Keywords: Breastfeeding support, CD-ROMs, Clinical coding, Hyperbilirubinemia, Newborn infants, Resource materials, Service coordination, Spanish language materials

Newman T. 1992. Laboratory Evaluation of Jaundiced Newborns A Reevaluation [Final report]. San Francisco, CA: University of California, San Francisco, 35 pp.

Annotation: This study sought to evaluate the validity of the standard textbook recommendations for the clinical laboratory approach to the diagnosis of jaundice in newborn infants. Since standards of care are based on traditional recommendations, the study looked at the specificity, sensitivity, and positive predictive value of each of the routine laboratory tests recommended for the evaluation of jaundiced infants. The study was retrospective and utilized several data bases, supplemented with chart reviews. The results showed that the prevalence of unsuspected significant illness in jaundiced infants is low, and the available laboratory tests have low sensitivity and specificity. The authors concluded that most routine laboratory tests in jaundiced infants are seldom useful. [Funded by the Maternal and Child Health Bureau]

Contact: National Technical Information Service, O.S. Department of Commerce, 5301 Shawnee Road, Alexandria, VA 22312, Telephone: (703) 605-6050 Secondary Telephone: (888) 584-8332 E-mail: [email protected] Web Site: http://www.ntis.gov Document Number: NTIS PB93-179992.

Keywords: Blood tests, Hyperbilirubinemia, Infant screening, Jaundice, Newborns

Odell GB, Schaffer R, Simopoulos AP, eds. 1974. Phototherapy in the newborn: An overview. Washington, DC: National Academy of Sciences, 190 pp.

Annotation: This volume includes selected papers from a symposium held in Washington, DC, February 12-13, 1973, under the sponsorship of the Committee on Phototherapy in the Newborn. Also provided are additional technical papers prepared by various members of the Committee. It is intended to be of interest to photobiologists, photochemists, bioengineers, physicists, medical researchers, and clinicians. Topics include the use of phototherapy; bilirubin; neonatal hyperbilirubinemia; bilirubin-dependent brain damage; phototherapy and preterm infants; circadian rhythms, and clinical management of infants with hyperbilirubinemia. Reference notes are provided at the end of each paper. [Funded by the Maternal and Child Health Bureau]

Keywords: Conferences, Hyperbilirubinemia, Neonatal jaundice, Neonatal screening, Phototherapy

American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114(1):297-316 July 2004 with Erratum 114(4):1138 October 2004., (Clinical practice guideline)

Annotation: These guidelines provide a framework for the prevention and management of hyperbilirubinemia in newborn infants of 35 or more weeks of gestation to reduce the risk of severe hyperbilirubinemia and bilirubin encephalopathy while minimizing the risks of unintended harm such as maternal anxiety, decreased breastfeeding, and unnecessary costs or treatments. Contents include a definition of recommendations and conditions, a description of the focus of the guideline, primary and secondary prevention, treatment, implementation strategies, and future research needs.

Contact: American Academy of Pediatrics, 345 Park Boulevard, Itasca, IL 60143, Telephone: (630) 626-6000 Secondary Telephone: (847) 434-4000 Fax: (847) 434-8000 Web Site: https://www.aap.org Available from the website.

Keywords: Guidelines, Hyperbilirubinemia, Infant health, Infant health services, Jaundice, Neonatal screening, Pediatric care, Resources for professionals
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.